These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14496914)

  • 1. The role of immunity in the pathogenesis of experimental hematogenous pyelonephritis.
    SANFORD JP; HUNTER BW; SOUDA LL
    J Exp Med; 1962 Feb; 115(2):383-410. PubMed ID: 14496914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE ROLE OF IMMUNITY IN THE PATHOGENESIS OF EXPERIMENTAL RETROGRADE PYELONEPHRITIS.
    HUNTER BW; AKINS LL; SANFORD JP
    J Exp Med; 1964 Jan; 119(6):869-79. PubMed ID: 14176291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against experimental Proteus mirabilis pyelonephritis in rats and significance of immunity.
    Larsson P; Kaijser B; Olling S; Akerlund AS
    Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):215-20. PubMed ID: 31056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
    Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
    Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunofluorescent demonstration of bacterial antigen in experimental pyelonephritis with antiserum against common enterobacterial antigen.
    Thomsen OF; Hjort T
    Acta Pathol Microbiol Scand A; 1973 Jul; 81(4):474-82. PubMed ID: 4205217
    [No Abstract]   [Full Text] [Related]  

  • 6. An experimental model for ascending acute pyelonephritis caused by Escherichia coli or proteus in rats.
    Larsson P; Kaijser B; Baltzer IM; Olling S
    J Clin Pathol; 1980 Apr; 33(4):408-12. PubMed ID: 6995491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria.
    Suankratay C; Jutivorakool K; Jirajariyavej S
    J Med Assoc Thai; 2008 Aug; 91(8):1172-81. PubMed ID: 18788687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in ankylosing spondylitis: effect of sulfasalazine treatment.
    Nissilä M; Lahesmaa R; Leirisalo-Repo M; Lehtinen K; Toivanen P; Granfors K
    J Rheumatol; 1994 Nov; 21(11):2082-7. PubMed ID: 7869314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan.
    Nakamura T; Komatsu M; Yamasaki K; Fukuda S; Miyamoto Y; Higuchi T; Ono T; Nishio H; Sueyoshi N; Kida K; Satoh K; Toda H; Toyokawa M; Nishi I; Sakamoto M; Akagi M; Nakai I; Kofuku T; Orita T; Wada Y; Zikimoto T; Koike C; Kinoshita S; Hirai I; Takahashi H; Matsuura N; Yamamoto Y
    Am J Clin Pathol; 2012 Apr; 137(4):620-6. PubMed ID: 22431539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell-mediated immunity in pyelonephritis: Passive transfer of adoptive immunity to retrograde Proteus mirabilis pyelonephritis in the rat (author's transl)].
    Araki T
    Nihon Hinyokika Gakkai Zasshi; 1977 Aug; 68(8):771-9. PubMed ID: 335141
    [No Abstract]   [Full Text] [Related]  

  • 11. [The urinary bacterial flora in patients with cutaneous ureterostomy].
    Murai R; Kubota S; Kim JC
    Hinyokika Kiyo; 2014 Dec; 60(12):605-9. PubMed ID: 25602475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Chu Y; Chen S; Cao B; Su J; Duan Q; Zhang S; Shao H; Kong H; Gui B; Hu Z; Badal R; Xu Y
    BMC Infect Dis; 2017 Dec; 17(1):776. PubMed ID: 29254478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary and serum o-antibodies in patients with chronic pyelonephritis (author's transl)].
    Budde E; Naumann G; Nimmich W; Handschuck I
    Zentralbl Bakteriol Orig A; 1977 Sep; 239(1):104-12. PubMed ID: 339606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
    Park SD; Uh Y; Lee G; Lim K; Kim JB; Jeong SH
    APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
    Mobley HL; Island MD; Massad G
    Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
    Liu HC; Hung YP; Lin HJ; Liu HC; Lee JC; Wu YH; Li CW; Li MC; Ko WC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):584-90. PubMed ID: 26692184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis.
    Silverblatt FJ; Ofek I
    J Infect Dis; 1978 Nov; 138(5):664-7. PubMed ID: 361900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local immune response in experimental pyelonephritis in the rabbit. II. Lymphocyte stimulation by lipopolysaccharide of infecting organism.
    Smith JW
    Immunology; 1975 Dec; 29(6):1077-85. PubMed ID: 1104473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.